“High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”

BACKGROUND: Germline BRCA1/2 pathogenic variant (PV) carriers have high lifetime risk of developing breast cancer and therefore subjected to intense lifetime screening. However, solid data on the effectiveness of high-risk screening of the BRCA1/2 carrier population is limited. PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Shraga, Shay, Grinshpun, Albert, Zick, Aviad, Kadouri, Luna, Cohen, Yogev, Maimon, Ofra, Adler-Levy, Yael, Zeltzer, Galina, Granit, Avital, Maly, Bella, Carmon, Einat, Meiner, Vardiella, Sella, Tamar, Hamburger, Tamar, Peretz, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443779/
https://www.ncbi.nlm.nih.gov/pubmed/34540661
http://dx.doi.org/10.3389/fonc.2021.683656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443779/
https://www.ncbi.nlm.nih.gov/pubmed/34540661
http://dx.doi.org/10.3389/fonc.2021.683656

Ejemplares similares